Jhajharia Ashok, Yadav Sumit, Singh Shashank, Ashdhir Prachis, Nijhawan Sandeep
Gastroenterology, Sawai Man Singh Medical College and Hospital, Jaipur, India.
Endoscopy. 2025 Feb;57(2):107-115. doi: 10.1055/a-2408-6905. Epub 2024 Sep 18.
Bleeding from gastric varices is life-threatening, with significant rebleeding risk despite standard cyanoacrylate glue injection therapy. Our aim was to evaluate the efficacy and safety of endoscopic ultrasonography (EUS)-guided coil embolization with cyanoacrylate injection (Coil+CYA) compared with EUS-guided cyanoacrylate injection alone (CYA) for the treatment of gastric varices.
The study was conducted at a tertiary referral center in India, using a single-blinded, prospective, and parallel-group randomized design. A total of 50 patients were randomly assigned (1 : 1) to Coil+CYA or CYA. The primary outcome was clinical success (i.e. variceal obliteration). Secondary outcomes involved technical success, gastric variceal recurrence during follow-up, rebleeding episodes, reintervention, and survival.
Post-intervention, gastric variceal obliteration assessed by EUS was higher in the Coil+CYA group (100% vs. 92.3%; = 0.49), with both groups achieving 100% technical success. Rebleeding episodes during 0-12 and 12-24 weeks were comparable in the two groups. At 12 weeks, on EUS, variceal reappearance was less common in the Coil+CYA group (12.5% vs. 19.2%; = 0.70). Significantly fewer reinterventions were needed in the Coil+CYA group (20.8% vs. 53.8%; = 0.03). The time to reintervention was significantly longer in the Coil+CYA group ( = 0.01), and the survival time was also longer ( = 0.04).
EUS-guided coil embolization with cyanoacrylate injection achieved superior clinical success, reducing the need for reintervention and resulting in improved survival compared with cyanoacrylate injection alone.
胃静脉曲张出血危及生命,尽管采用标准的氰基丙烯酸酯胶注射疗法,仍有显著的再出血风险。我们的目的是评估内镜超声(EUS)引导下线圈栓塞联合氰基丙烯酸酯注射(Coil+CYA)与单纯EUS引导下氰基丙烯酸酯注射(CYA)治疗胃静脉曲张的疗效和安全性。
该研究在印度的一家三级转诊中心进行,采用单盲、前瞻性和平行组随机设计。总共50例患者被随机分配(1:1)至Coil+CYA组或CYA组。主要结局是临床成功(即静脉曲张闭塞)。次要结局包括技术成功、随访期间胃静脉曲张复发、再出血事件、再次干预和生存率。
干预后,Coil+CYA组经EUS评估的胃静脉曲张闭塞率更高(100%对92.3%;P=0.49),两组的技术成功率均达到100%。两组在0至12周和12至24周期间的再出血事件相当。在12周时,经EUS检查,Coil+CYA组静脉曲张再次出现的情况较少见(12.5%对19.2%;P=0.70)。Coil+CYA组需要再次干预的情况明显更少(20.8%对53.8%;P=0.03)。Coil+CYA组再次干预的时间明显更长(P=0.01),生存时间也更长(P=0.04)。
与单纯氰基丙烯酸酯注射相比,EUS引导下线圈栓塞联合氰基丙烯酸酯注射取得了更好的临床成功,减少了再次干预的需求并提高了生存率。